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Objective: To analyze the safety degree of drugs used in colonoscopy during conscious seda-
tion  in patients developing respiratory depression.
Methods: Cross-sectional observational study that evaluated 1120 patients who underwent
colonoscopy between February 2015 and February 2016. Physical characteristics, surgical
history and previous colonoscopies, indication and conditions of the current examination,
fentanyl and midazolam doses and subsequent complications were analyzed. Level of sig-
niﬁcance: p < 0.05. Chi-square test was used for association of categorical variables, whereas
Student’s t test was used to compare means and Spearman’s coefﬁcient for correlation.
Results: There were 661 female (59%) and 459 (41%) male patients, with a mean age of 54.90
(20–87) years and BMI of 27.00 (14.5–45.4). Of the 1120 patients, only 2 (0.2%) had respiratory
depression, reversed with lanexat. Patients who had complications were of both genders,
with  a body mass index of 21.25 and 28.7. There was a correlation between the required
dose  of fentanyl and age (p < 0.001 to −0.121 Spearman’s coefﬁcient), as well as midazolam
(p  < 0.001 – Spearman’s coefﬁcient −0.452) and increasing age was associated with a lower
dose of the drug.
Conclusion: The number of patients with complications was 0.17%. The age of the patient
showed an inverse association, i.e., the older the patient, the lower the required dose of
medication. The drugs used in colonoscopy show a high degree of safety, corroborating
their frequent use for superﬁcial/conscious sedation in this procedure.©  2016 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. This
is  an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Please cite this article in press as: Rech FM, et al. Safety degree assessment of drugs used in conscious sedation for colonoscopy in patients that
develop respiratory depression. J Coloproctol (Rio J). 2016. http://dx.doi.org/10.1016/j.jcol.2016.09.003
 Study carried out at the Servic¸o de Endoscopia e Colonoscopia, Clínica Pró-Vida, Tubarão, SC, Brazil.
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Avaliac¸ão  do  grau  de  seguranc¸a  dos  fármacos  utilizados  na  sedac¸ão
superﬁcial  na  colonoscopia  em  pacientes  que  desencadeiam  depressão
respiratória
Palavras-chave:
Colonoscopia, Sedac¸ão
consciente, Complicac¸ão,
Sedac¸ão, Depressão respiratória
r  e  s  u  m  o
Objetivo: Analisar o grau de seguranc¸a dos fármacos utilizados na colonoscopia sob sedac¸ão
superﬁcial em pacientes que desencadeiam depressão respiratória.
Métodos: Estudo observacional transversal, que avaliou 1.120 pacientes que realizaram
colonoscopia entre Fevereiro de 2015 e Fevereiro de 2016. Analisaram-se características
físicas, histórico cirúrgico e colonoscopias prévias, indicac¸ão e condic¸ões do exame atual,
dose  de fentanil e midazolam e complicac¸ões apresentadas. Nível de signiﬁcância adotado:
p  < 0,05. Utilizou-se teste Qui-quadrado para associac¸ão de variáveis categóricas, teste t de
Student para comparac¸ão de médias e coeﬁciente de Spearman para correlac¸ão.
Resultados: Foram 661 pacientes do sexo feminino (59%) e 459 (41%) do sexo masculino,
com média de idade de 54,90 (20-87) anos e IMC de 27,00 (14,5-45,4). Dos 1120 pacientes,
apenas 2 (0,2%) exibiram depressão respiratória revertida com lanexate. Os pacientes que
apresentaram complicac¸ão eram de sexos diferentes, com índices de massa corpórea de
21,25  e 28,7. Houve correlac¸ão entre a dose necessária de fentanil e a idade (p < 0,001 -
coef  Spearmann - 0.121), assim como a de midazolam (p < 0,001 - coef Spearmann - 0.452),
sendo que com o aumento da idade se correlacionou com uma menor dose utilizada de
medicamento.
Conclusão: O número de pacientes que apresentaram alguma complicac¸ão foi 0,17%. A
idade do paciente tem associac¸ão inversa, quanto maior a idade do paciente, menor é a
dose necessária de medicamentos. Veriﬁca-se alto grau de seguranc¸a dos medicamentos
utilizados na colonoscopia, corroborando sua utilizac¸ão frequente para a sedac¸ão superﬁ-
cial/consciente neste procedimento.
© 2016 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda. Este
e´  um artigo Open Access sob uma licenc¸a CC BY-NC-ND (http://creativecommons.org/Introduction
Colonoscopy is a safe endoscopic examination, which pro-
vides information that common radiological tests may not
be able to disclose. Colonoscopy has the advantage of being
used both for the diagnosis and treatment of some colorectal
diseases.1
Despite its importance, patients undergoing colonoscopy
frequently have many  questions and concerns about the pro-
cedure. Because it is an invasive procedure, it may have its
performance hindered by factors such as patient anxiety and
discomfort, who in addition to fear of pain, also must face the
possibility of diagnosis of a severe illness.2
Several factors are associated with increased likelihood of
feeling discomfort during colonoscopy, which can be inher-
ent or not to the patient. Being very young or of older
age, female gender, low body mass index (BMI), previous
abdominal or pelvic surgery, inadequate colon preparation,
inadequate sedation, kinking, high pressure of the air blown
for colon distention are some of these factors.3 An experienced
endoscopist, adequate colon preparation, patient compliance
and effective analgesia and sedation are required for an effec-
tive and good-quality examination.2–4Please cite this article in press as: Rech FM, et al. Safety degree assessment
develop respiratory depression. J Coloproctol (Rio J). 2016. http://dx.doi.org
The best type of sedation/analgesia for gastrointestinal
endoscopic procedures has yet to be deﬁned,5 although, it is
believed that sedation administration before the procedurelicenses/by-nc-nd/4.0/).
is safer for the patient and the endoscopist.6,7 Both deep
sedation and superﬁcial sedation and analgesia are options
for colonoscopies. When deeper sedation is desired, usually
an anesthesiologist is called to follow the examination. Con-
scious sedation allows patients to give verbal responses or
respond to tactile stimulation and allows control of respiratory
and cardiovascular functions.5
Therefore, the most adequate medication for sedation dur-
ing colonoscopy is that with an immediate effect and that
lasts only for the duration of the examination, resulting in
a rapid patient recovery and cause few or no side effects.8
Benzodiazepines are routinely used associated with opioids.
Midazolam is a benzodiazepine that reduces anxiety and is
used in patient sedation. It has an onset of action of 1–2 min
after intravenous administration of 5 mg and has a quick
recovery. Fentanyl is a short-acting opioid, of which effect
takes place within 2 min  after the intravenous administra-
tion of 1–2 mg/kg and is responsible for anesthesia and pain
reduction during the examination.9
The examination starts with the patient placed in left lat-
eral decubitus, after adequate colon preparation and sedation
by peripheral venous access, monitored by pulse oximetry.
The perianal and anal region are inspected for the presence of of drugs used in conscious sedation for colonoscopy in patients that
/10.1016/j.jcol.2016.09.003
lesions, and digital rectal examination is performed for dila-
tion of the anal sphincter and evaluation of possible tumor
masses. If general anesthesia is not being used, the patient
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ay experience cramping or severe pain, resulting from tube
ovement  and can also feel the urge to evacuate.
The colonoscopy should evaluate the mucosa of all colon
egments, both at the introduction and the withdrawal of the
evice. Some landmarks are used by the endoscopist to better
ocate the colonoscope during the procedure. The bluish shade
f the spleen, seen by transparency, identiﬁes the splenic ﬂex-
re. The second shade, more  extensive, consists of the liver
nd identiﬁes the hepatic ﬂexure. The appendicular ostium is
ocated in the center of the triangle formed by the convergence
f teniae coli, in the cecum. The ileal papilla can be identiﬁed
hrough a bilabiate fold located in the transition between the
scending colon and the cecum. The examination is consid-
red complete when the examiner can identify the cecum,
leal papilla and appendicular ostium and the colonoscope
ust be introduced in the ileal papilla to evaluate the terminal
leum.2
The colonoscopy performance may lead to complications
rising from the preparation, sedation and diagnostic and/or
herapeutic procedures. These events, which are relatively
ommon, have a morbidity rate of around 1% and are usu-
lly transient and underreported. Among the complications
elated to the drugs used for sedation are local reactions,
uch as superﬁcial phlebitis at the site of benzodiazepine
njection and localized itching due to use of opioids.5 Sys-
emic reactions caused by the drugs are more  signiﬁcant
nd potentially more  dangerous, with most of them being
ardiorespiratory-related. The most common are: hypoven-
ilation, hypertension, hypotension, hypoxia, tachycardia,
radycardia. Some may be potentiated by the pain and dis-
omfort of patients, requiring higher doses of sedatives.6
The aim of this study is to analyze the safety degree of
he drugs used in colonoscopy procedures in patients under
uperﬁcial sedation, identify possible complications resulting
rom the drug doses, correlating them with the presence of
omplications.
ethods
his was an observational study with a cross-sectional design,
hich was approved by the Research Ethics Committee of Uni-
ersidade do Sul de Santa Catarina under opinion n. 875,131,
AAE 49379915.5.0000.5369, according to the standards of the
ational Health Council for research involving human sub-
ects, resolution 466/2012.
Patients treated on an outpatient basis between February
015 and February 2016 were evaluated at the Endoscopy and
olonoscopy Service at Clínica Pró Vida, in the municipality
f Tubarão, state of Santa Catarina, Brazil. Based on the num-
er of monthly consultations at the service, of approximately
00 consultations/month, it was estimated a sample of 1000
atients.
The study included all patients submitted to colonoscopy at
he Endoscopy and Colonoscopy Service at Clínica Pró Vida in
ubarão, Santa Catarina, from February 2015 to February 2016.Please cite this article in press as: Rech FM, et al. Safety degree assessment
develop respiratory depression. J Coloproctol (Rio J). 2016. http://dx.doi.org
atients who required emergency examinations or who were
ubmitted to deep sedation were excluded from this study.
All patients received a diet without residues on the day
efore the examination, followed by a 12-h fasting. On the;x x x(x x):xxx–xxx 3
day of the colonoscopy, colon preparation was performed with
a balanced polyethylene glycol solution, 1000 mL  adminis-
tered orally 3 h before the examination, associated with the
antiemetic drug ondansetron, 8 mg  orally.
Midazolam at a dose of 0.1 mg/kg of weight and intravenous
fentanyl, 1 mcg/kg, were used for patient sedation and anal-
gesia, immediately before the examination. In patients older
than 70 years, the initial dose of midazolam was 0.05 mg/kg.
Drugs were administered simultaneously and a second dose
of midazolam was administered in cases where the patient
expressed pain, usually half of the initial one, 0.05 mg/kg.
Monitoring of vital signs was carried out with pulse
oximetry and, when necessary, oxygen supplementation was
provided with a mask. The criterion used for respiratory
depression was a respiratory rate <8–10 bpm or decreased oxy-
gen saturation (SpO2) recorded in pulse oximetry. Patients
with oxygen saturation ≤70% were treated for respiratory
depression. Sedation and monitoring were performed by the
endoscopists participating in the study, all of which were pro-
fessionals with more  than 10 years of experience. The devices
used for the colonoscopy were Pentax
®
EPK 1000 Series.
Data were collected through a Medical Record for Anal-
ysis, containing age, gender, weight, height, BMI, indication
(diagnostic or therapeutic) and reason for colonoscopy (which
disease was to be investigated and/or treated or what type
of treatment was used), if there was prior abdominal and/or
pelvic surgery and previous colonoscopy examinations, time
of examination, adequate or inadequate colon preparation,
complete or incomplete examination, dose of fentanyl and
midazolam used and subsequent complications, if any.
The drugs used for sedation and analgesia during the
examination are the ones routinely used in procedures at the
Endoscopy and Colonoscopy Service of Clínica Pró Vida, in all
patients submitted to colonoscopy. The study did not require
the signing of the free and informed consent form and used
only a justiﬁcation for not using the Term of Informed Consent
in cases of research using medical records.
Data were recorded in a spreadsheet using the EpiInfo
®
program, version 3.5.4 and analyzed with the program SPSS,
version 20.0. The signiﬁcance level was set at less than 5%
(p < 0.05). The description of the variables was performed using
means and standard deviations for numerical variables and
relative frequencies for categorical variables. The chi-square
test was used for the association of categorical variables, while
Student’s t test was used for the comparison of means and
the correlation of variables used Spearman’s correlation coef-
ﬁcient, with rho () between −1 and +1.
Results
Of the 1120 patients evaluated, 661 were females (59%) and 459
(41%) males, with a mean age of 54.90 (20–87) years. The mean
BMI  of the patients was 27 (14.5–45.4), with a mean height of
163 cm and mean weight of 67.38 kg. of drugs used in conscious sedation for colonoscopy in patients that
/10.1016/j.jcol.2016.09.003
Table 1 shows the characteristics of patients in relation to
gender, age, BMI, number (%) of patients submitted to prior
colonoscopy, how many  had adequate colon preparation and
how many  patients had a complete examination. Patients with
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Table 1 – General aspects of patients submitted to
colonoscopy under conscious sedation in a private clinic
in Tubarão (SC).
Characteristics Number (%)
Gender
Female 661 (59.0%)
Male 459 (41%)
Age (mean)
<54.87 years 478 (42.7%)
≥54.87 years 642  (57.3%)
BMI
<18.5 15 (1.3%)
≥18.5 < 25.0 372 (33.3%)
≥25.0 < 30.0 463 (41.3%)
≥30.0 270 (24.1%)
Previous colonoscopy
Yes 252 (22.5%)
No 868 (77.5%)
Colon preparation
Adequate 1102 (98.4%)
Inadequate 18(1.6%)
Complete examination
Yes 1077 (96.2%)
No 43 (3.8%)
BMI, body mass index.
Table 2 – Indications for colonoscopy under conscious
sedation in a private clinic in Tubarão (SC).
Indication Frequency (%)
Abdominal pain 316 (28.2%)
Intestinal bleeding 229 (20.5%)
Change in bowel habit 160 (14.3%)
Familial screening 150 (13.4%)
History of colorectal cancer/polyposis 49 (4.4%)
Indication not mentioned 36 (3.2%)
Anemia 33 (3%)
Intestinal inﬂammatory disease 40 (3.6%)
Oncologic follow-up 40 (3.6%)
Follow-up post-polypectomy 29 (2.5%)
Weight loss 16 (1.5%)
Proctalgia/tenesmus 12 (1.1%)
Endometriosis 3 (0.3%)
Pre/Postoperative procedure 3 (0.3%)
CEAa level alteration 2 (0.2%)
Portal hypertension 1 (0.1%)
Altered rectal digital examination 1 (0.1%)
Total 1120 (100%)
Table 3 – List of doses and means of drugs in mg used in
colonoscopy under conscious sedation in a private clinic
in Tubarão (SC).
Medication Total Minimum Maximum Mean
Fentanyl dose 1120 patients 0 0.25 0.05a Carcinoembryonic antigen.
complications had adequate colon preparation and a complete
examination.
Table 2 shows patients’ indications for the colonoscopy.
Of the total number of patients, 1092 (97.5%) had a diagnos-
tic colonoscopy indication and 28 (2.5%) had a therapeutic
indication. Patients with complications had an indication forPlease cite this article in press as: Rech FM, et al. Safety degree assessment
develop respiratory depression. J Coloproctol (Rio J). 2016. http://dx.doi.org
diagnostic colonoscopy, one of them due to abdominal pain
and another due to change in bowel habits.Midazolam dose 1120 patients 1 11 5.19
The mean number of prior pelvic and abdominal surgeries
was 1.06 per person; 508 (45.35%) had not been submitted to
any type of surgical procedure, while 612 (54.64%) had under-
gone some type of surgery. Of the patients with complications,
both had undergone some type of surgical intervention.
Regarding medications, 210 patients received additional
doses of midazolam. The mean midazolam dose administered
to patients without complications was 5.19 mg (minimum
dose of 1 mg  and maximum dose of 11 mg), while the mean
fentanyl dose was 0.05 mg  (minimum dose of 0 mg  and maxi-
mum dose of 0.25 mg). The mean dose used in the two patients
with complications was 20 mg  of midazolam and 0.05 mg of
fentanyl (Table 3).
There was a correlation between the necessary dose of fen-
tanyl and age (p < 0.001 – Spearman’s coefﬁcient of −0.121).
The negative Spearman coefﬁcient shows an inverse associ-
ation, with increasing age correlating with a lower dose of
fentanyl. There was also a correlation between the necessary
dose of midazolam and age (p < 0.001 – Spearman’s coefﬁcient
of −0452). The negative Spearman coefﬁcient shows an inverse
association, with increasing age correlating with a lower dose
of midazolam. There was no signiﬁcant correlation between
the dose of fentanyl and the dose of midazolam with BMI.
Of the 1120 patients, 1118 (99.8%) did not have any com-
plications, while 2 (0.2%) had respiratory depression reversed
with lanexat. Patients who had complications were of differ-
ent genders, with a BMI of 21.25 (male gender – 1.68 m and
60 kg) and 28.7 (female gender – 1.56 m and 70 kg).
The mean weight in patients without complications was
73.39 kg/BMI 26.51, and in cases with complications was
65 kg/BMI 24.97. The mean age in the cases of respiratory
complications was 72 years, whereas in those with no com-
plications was 54.87 years (Table 4).
According to the analysis, no signiﬁcant association was
veriﬁed between age, weight, BMI, dose of fentanyl and mida-
zolam with the observed complications. The mean duration of
the colonoscopy in the patients was 7.47 min. It was observed
that even with a longer colonoscope insertion time, corre-
sponding to the time elapsed since the unit was introduced
until it reached the cecum, it was not associated with respira-
tory depression observed in two patients, in whom the mean
duration of the examination was 9 min.
Discussion
Colonoscopy is an examination of utmost importance in colo-
proctology and associated specialties. Even though the patient
may feel some discomfort in several situations, it is still one of drugs used in conscious sedation for colonoscopy in patients that
/10.1016/j.jcol.2016.09.003
of the safest examinations to be performed with a low com-
plication rate.
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Table 4 – Correlation between complications and other variables observed in patients submitted to colonoscopy under
conscious sedation.
Age (years) Weight (kg) BMI (kg/m2) Fentanyl dose
(mg)
Midazolam
dose (mg)
With complication (2 patients) 72 65 24.97 0.05 20.00
No complications (1118 patients) 54.87 73.39 26.51 0.05 5.19
p value 0.084 0.669 0.875 1 0.185
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There are several indications for a colonoscopy. Contraindi-
ations are increasingly restricted and most of them are only
elative ones. The most frequent indications in this study were
bdominal pain (n = 316; 28.2%), intestinal bleeding (n = 229;
0.5%) and change in bowel habits (n = 160; 14.3%). According
o the study by Silva et al.,10 there are reports of similar indi-
ations such as diarrhea, anal bleeding and abdominal pain.
lthough it is a routine examination, it has a non-negligible
orbidity, whether regarding the preparation, sedation, the
xamination or the therapy. The examination is often required
n the elderly and/or patients with comorbidities, which con-
ributes to increased morbidity.
Most scientiﬁc studies related to complications inherent to
olonoscopy aim to study complications such as perforation
nd bleeding. The present study assessed the complications
elated to the drugs used in colonoscopy, emphasizing respira-
ory depression. It is noteworthy that, even though there was
ssociated morbidity, colon preparation in this study was clas-
iﬁed as adequate in most patients (n = 1102; 98.4%). After all,
s reported in the study of Habr-Gama et al.,11 this variable is of
tmost importance in this examination and possible resulting
omplications.
The colonoscopies were performed under conscious
edation with benzodiazepines and opioid analgesics, admin-
stered concomitantly to enhance sedation. Midazolam has a
imited effect on the cardiovascular and respiratory systems,
ausing little change in blood pressure (BP) and only a tran-
ient depression. Its most prominent and easily quantiﬁable
ction is the central nervous system (CNS) depression. Respi-
atory depression remains one of the most feared adverse
ffects during anesthesia with opioids. Its incidence in adults
escribed in the literature varies widely, mainly due to the
ifferent deﬁnitions used by the authors.2 Commonly, studies
onsider a respiratory rate lower than 8–10 bpm or decreased
xygen saturation (SpO2) recorded in pulse oximetry.3 In this
tudy, patients with oxygen saturation ≤70% were treated for
espiratory depression.
In addition to the side effects associated to preparation
nd sedation, the examination also has the potential to cause
omplications due to the air insufﬂation in the digestive
ract, mesocolon traction and pain experienced by the patient,
riggering or worsening complications such as increase or
ecrease in BP, bradycardia, asystole or leading to the need for
igher doses of hypnotics and hypoanalgesics. Mean doses of
.19 mg  of midazolam and 0.05 mg  of fentanyl were used, withPlease cite this article in press as: Rech FM, et al. Safety degree assessment
develop respiratory depression. J Coloproctol (Rio J). 2016. http://dx.doi.org
 maximum dose of each drug, of 11 mg  and 0.25 mg,  and a
inimum dose of 1 mg  and 0 mg,  respectively.
Due to the sedation/examination, of 1120 patients, two
ad respiratory depression as a complication. This alteration27
1120
0.05
1120
5.21
1120
occurred in a minority of patients and was easily resolved
with the use of lanexat (ﬂumazenil), with both patients receiv-
ing oxygen supplementation through a mask, with no need
for orotracheal intubation. The criteria used for respiratory
depression included all patients with oxygen saturation ≤70%,
who required intervention. Lanexat is indicated in the com-
plete or partial reversal of the central sedative effects of
benzodiazepines. Therefore, it is used in anesthesia and inten-
sive care units. The drug aims to counteract the sedative
effects of benzodiazepines for short-duration diagnostic and
therapeutic procedures, reestablishing spontaneous respira-
tion and consciousness to avoid intubation and subsequent
extubation.
BP monitoring throughout the examination is crucial
to prevent possible worsening of morbidities. The impor-
tance of using pulse oximetry during the examination is
well-established, aiming to diagnose and promptly correct
decreased oxygen saturation, tachycardia or bradycardia,
especially in the elderly and/or in patients with comorbidi-
ties. The depressed level of consciousness entails a reduction
in oxygen saturation.
The present study demonstrated that regardless of all
the factors that can contribute to complications during
colonoscopy, of the total 1120 patients enrolled in the study,
1118 (99.82%) tolerated the examination very well, without any
complications or decompensation events.
Regarding the increasing age of patients undergoing the
examination and the complications, it was observed that
with increasing age, lower doses were required for conscious
sedation.12 As mentioned in the literature, it is noteworthy
the direct association between increased cardiovascular risks
and other complications after colonoscopy due to increased
age.13 The mean weight in patients without complications
was 73.39 kg/BMI 26.51, and in cases with complications was
65 kg/BMI 24.97. There was no signiﬁcant association between
the doses of fentanyl and of midazolam with BMI. However,
previous studies with a larger number of cases of patients with
complications observed that the higher the BMI, the higher the
doses used in patients for conscious sedation.7
Another parameter that determines the progress and
effectiveness of the examination is colon preparation. This
illustrates the fundamental importance of good colon prepa-
ration, customizing it for each patient, aiming to reduce the
complications that arise from inadequate preparation. The
dirtier the colon, the more  difﬁcult is the examination and of drugs used in conscious sedation for colonoscopy in patients that
/10.1016/j.jcol.2016.09.003
the colonic mucosa may be only partially visualized, which
can hinder the diagnosis of lesions (polyps and ﬂat lesions,
mainly) and there is a greater chance of complications. In
our study, there was no direct association between colon
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preparation and complications. Both patients had adequate
colon preparation and a complete examination was attained.
As for the association between gender and complications,
although it was not found in this analysis, there are articles
that suggest an increased risk of complications in women due
to gynecologic surgeries that contribute to the lower tolerance
of women to colonoscopy.14 It is believed that colonoscopy is
more  difﬁcult in these patients due to the formation of adhe-
sions, common in patients with previous abdominal-pelvic
surgeries.
Very often, the technical difﬁculty is not associated with
any patient-related factor, but to the examiner’s experience.
It is known that more  experienced endoscopists have fewer
technical difﬁculties when performing colonoscopy,14 there-
fore, patients with risk factors for complications should be
examined by them, while patients with an easier examina-
tion proﬁle should be examined by endoscopists with less
experience.16 All endoscopists participating in the study have
more than 10 years of experience.
Colonoscopy can be performed without any analgesia;
however, because it is an invasive procedure and many
patients have anxiety and fear of pain, most endoscopy
services use some type of conscious sedation, through the
association of benzodiazepines and opioids.
Midazolam is a benzodiazepine that reduces anxiety and
is used in patient sedation and fentanyl is a short-acting opi-
oid, responsible for analgesia during the examination. Both
have an onset of action of approximately 2 min  after the
intravenous administration and fast recovery,15 respecting the
principles of conscious sedation. It was observed that 210
patients received extra doses of midazolam in addition to
the initial one, but the mean administered dose in patients
who  had complications was not signiﬁcantly higher than that
administered to patients who did not receive them. Thus,
the group that did not show alterations received a mean
dose of midazolam of 5.19 mg  and the minority with com-
plications received a dose of 20 mg.  The mean fentanyl dose
was 0.05 mg,  both for patients with and without complica-
tions.
A third study, after comparing two groups of patients,
one using only midazolam and the other using only fen-
tanyl, showed that the group receiving fentanyl showed a
higher level of satisfaction and shorter recovery time. In
this study, during the examination, patients in the fentanyl
group required fewer decubitus changes, none had mental
confusion and the duration of the procedure was signiﬁ-
cantly shorter.16 Thus, sedation and analgesia should be more
customized, by previously researching the biophysical and
psychological proﬁle of the patient. Patients with risk factors
such as female gender, anxious patients, those with low BMI
could receive a more  intense sedation. Respiratory depression,
regardless of the opioid administration route, does not occur
abruptly. It is a complication that is always accompanied by
other central nervous system depression signs, such as seda-
tion. Analgesia precedes sedation, which in turn, precedes
the respiratory depression. Still, the low rate of complica-
tions observed in the study demonstrated the high degree ofPlease cite this article in press as: Rech FM, et al. Safety degree assessment
develop respiratory depression. J Coloproctol (Rio J). 2016. http://dx.doi.org
safety of the drugs used during colonoscopy, corroborating
their frequent use for superﬁcial/conscious sedation for this
procedure.6;x x x(x x):xxx–xxx
Conclusion
Colonoscopy is a safe examination when performed under
conscious sedation, as even though several factors contribute
to the emergence of possible complications, in this study
the number of patients with complications was 0.17%, with
respiratory depression. Patient age showed an inverse asso-
ciation, i.e., the older the patient, the lower the required
dose of medication. The low rate of complications in the
study demonstrated the high degree of safety of the drugs
used during colonoscopy, corroborating their frequent use for
superﬁcial/conscious sedation for this procedure.
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